Vasiliki Pelekanou

4PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 28, 2021
Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry.

Sandra Martinez-Morilla, Franz Villarroel-Espindola, Pok Fai Wong

|Dec 19, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.

Vasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper

|Mar 29, 2018
Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial.

Vasiliki Pelekanou, William E Barlow, Zeina A Nahleh

|Aug 09, 2017
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.

Vasiliki Pelekanou, Daniel E Carvajal-Hausdorf, Mehmet Altan

Pageof 1

Frequent Collaborators

1 joint publications

Thazin Nwe Aung

1 joint publications

David L Rimm